ストックスクリーナーアプリを入手
241.12
1.11%
-2.71
前日終値:
$243.83
開ける：
$241.23
24時間の取引高:
855.99K
Relative Volume:
0.98
時価総額：
$17.37B
収益：
$2.96B
当期純損益:
$487.70M
株価収益率:
36.12
EPS:
6.6758
ネットキャッシュフロー:
$344.00M
1週間 パフォーマンス:
-3.74%
1か月 パフォーマンス:
-3.74%
6か月 パフォーマンス:
-2.13%
1年 パフォーマンス:
+18.40%
1日の値動き範囲:
$239.27
$245.36
1週間の範囲:
$239.27
$251.81
52週間の値動き範囲:
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
241.12 | 17.57B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
504.05 | 177.40B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
185.39 | 51.91B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
49.80 | 39.61B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
82.63 | 40.88B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.12 | 37.34B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 開始されました | Barclays | Equal Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
How sensitive is West Pharmaceutical Services Inc. to inflationGold Moves & Weekly Breakout Watchlists - mfd.ru
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth - Insider Monkey
Vanguard Group Inc. Buys 388,144 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by ICICI Prudential Asset Management Co Ltd - MarketBeat
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock? - Yahoo Finance
Customer Concentration Risk: How Dependence on Key Accounts Threatens West Pharmaceutical’s Financial Stability - The Globe and Mail
Risk Recap: What’s the outlook for West Pharmaceutical Services Inc.’s sectorWeekly Trend Recap & AI Enhanced Market Trend Forecasts - mfd.ru
Pharmaceutical Packaging Market Trends and Growth - GlobeNewswire
Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players - Yahoo Finance
Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings - MyChesCo
5 Insightful Analyst Questions From West Pharmaceutical Services's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call - TradingView
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Galapagos (GLPG) and West Pharmaceutical Services (WST) - The Globe and Mail
West Pharmaceutical Services, Inc. (NYSE:WST) Declares $0.22 Quarterly Dividend - MarketBeat
Assetmark Inc. Sells 26,486 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Share Repurchase Plan Declared by West Pharmaceutical Services (NYSE:WST) Board of Directors - Defense World
West Pharmaceutical Services (NYSE:WST) to Buyback $1.00 billion in Outstanding Shares - MarketBeat
West Pharmaceutical announces up to $1B share repurchase program - MSN
West Pharmaceutical Services Maintains Quarterly Dividend, Authorizes $1 Billion Share Repurchase - marketscreener.com
West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on May 6, 2026 - marketscreener.com
West Pharmaceutical Declares Quarterly Dividend and Share Repurchase Program - Intellectia AI
West Announces Quarterly Dividend and Share Repurchase Program - Nasdaq
Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term - Yahoo Finance
How West Pharmaceutical Services Inc. (WST) Affects Rotational Strategy Timing - Stock Traders Daily
West Pharmaceutical Services launches Synchrony S1 prefillable syringe system - Traders Union
West Pharmaceutical Services (WST) Stock Analysis: A Look At Its 27% Potential Upside - DirectorsTalk Interviews
WST's Q4 earnings & sales beat, SmartDose sale by mid-2026, stock up - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Sees Significant Increase in Short Interest - MarketBeat
What’s the outlook for West Pharmaceutical Services Inc.’s sectorPrice Action & Technical Confirmation Alerts - mfd.ru
Earnings Release: Here's Why Analysts Cut Their West Pharmaceutical Services, Inc. (NYSE:WST) Price Target To US$319 - 富途牛牛
Cibc World Market Inc. Has $4.88 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Caprock Group LLC Purchases New Shares in West Pharmaceutical Services, Inc. $WST - MarketBeat
How Investors Are Reacting To West Pharmaceutical (WST) GLP-1 Momentum And Upbeat 2026 Sales Guidance - Sahm
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q4 Earnings Call Highlights - MarketBeat
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates - MSN
West Pharma forecasts 2026 profit above estimates on strong demand for drug components - 104.1 WIKY
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook - Yahoo Finance
Earnings call transcript: West Pharmaceutical Services Q4 2025 earnings beat expectations - Investing.com Canada
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations - Investing.com Nigeria
West Pharmaceutical Services (NYSE:WST) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat
West Pharmaceutical Services Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI
West Pharmaceutical Services's (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Finviz
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - Finviz
Iron Mountain Projects Double-Digit Growth in 2026 - Investing.com
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations By Investing.com - Investing.com India
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Issues FY 2026 Earnings Guidance - MarketBeat
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.91%
大文字化:
|
ボリューム (24 時間):